Get started
222

HANA PHARM

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

293480 chart


Full chart

Key stats


Market capitalization
‪195.83 B‬ KRW
Dividend yield (indicated)
4.51%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
1,180 KRW
Net income (FY)
‪22.33 B‬ KRW
Revenue (FY)
‪224.46 B‬ KRW
Shares float
‪7.30 M‬
Beta (1Y)
0.24

Employees


Employees (FY)
707
Change (1Y)
+33 +4.90%
Revenue / Employee (1Y)
‪243.82 K‬ KRW
Net income / Employee (1Y)
‪24.26 K‬ KRW

About HANA PHARM


Sector
Health Technology
CEO
Tae-Hong Choi
Headquarters
Hwaseong-si
Website
hanaph.co.kr
Founded
1978
ISIN
KR7293480000
FIGI
BBG00LSC4127
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. Its products include medicines in the form of tablets, capsules, liquid injections, polypropylene ampoule injections, freeze-dried and non-sterile Vial injections, pre-filled syringe injections, and liquid suction. The company was founded on January 19, 1978 and is headquartered in Hwaseong-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

293480 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 293480 is 11,340 KRW — it has increased by 0.18% in the past 24 hours. Watch HANA PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANA PHARM stocks are traded under the ticker 293480.
293480 stock has risen by 1.80% compared to the previous week, the month change is a 0.44% rise, over the last year HANA PHARM has showed a −17.71% decrease.
We've gathered analysts' opinions on HANA PHARM future price: according to them, 293480 price has a max estimate of 18,000.00 KRW and a min estimate of 18,000.00 KRW. Watch 293480 chart and read a more detailed HANA PHARM stock forecast: see what analysts think of HANA PHARM and suggest that you do with its stocks.
293480 reached its all-time high on Oct 2, 2018 with the price of 34,950 KRW, and its all-time low was 10,780 KRW and was reached on Oct 25, 2024. View more price dynamics on 293480 chart.
See other stocks reaching their highest and lowest prices.
293480 stock is 1.42% volatile and has beta coefficient of 0.24. Track HANA PHARM stock price on the chart and check out the list of the most volatile stocks — is HANA PHARM there?
Today HANA PHARM has the market capitalization of ‪195.83 B‬, it has increased by 0.73% over the last week.
Yes, you can track HANA PHARM financials in yearly and quarterly reports right on TradingView.
293480 net income for the last quarter is ‪5.03 B‬ KRW, while the quarter before that showed ‪6.08 B‬ KRW of net income which accounts for −17.18% change. Track more HANA PHARM financial stats to get the full picture.
Yes, 293480 dividends are paid annually. The last dividend per share was 510.00 KRW. As of today, Dividend Yield (TTM)% is 4.51%. Tracking HANA PHARM dividends might help you take more informed decisions.
HANA PHARM dividend yield was 3.66% in 2023, and payout ratio reached 39.51%. The year before the numbers were 2.79% and 36.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 707.00 employees. See our rating of the largest employees — is HANA PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANA PHARM EBITDA is ‪−90.28 B‬ KRW, and current EBITDA margin is 15.02%. See more stats in HANA PHARM financial statements.
Like other stocks, 293480 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANA PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANA PHARM technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANA PHARM stock shows the sell signal. See more of HANA PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.